1-9 of 9
Sheila J.M. O’Connor, PhD
Close
Sort by
Journal Articles

The Utility Of Minimal Residual Disease (MRD) Assessment At First Relapse: Results From The BSBMT/Ukmf Myeloma X (Intensive) Trial

John Ashcroft, MD, MBBChir, PhD, MRCP, MA, FRCPath, Ruth M de Tute, MSc, David A Cairns, PhD, Marie Fletcher, Roger G Owen, MD, Andy Rawstron, PhD, Sheila J.M. O'Connor, PhD, Cathy D. Williams, MBBS, MCRP, FRCPath, John A Snowden, MD, FRCP, FRCPath, J. D. Cavenagh, MD, MRCP, Christopher Parrish, MA, MB, BChir, MRCP, Treen Morris, Julia MB Brown, Gordon Cook, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3378.
https://doi.org/10.1182/blood.V122.21.3378.3378
Published: 2013
Journal Articles

TP53 Deletion in CLL: The Significance of Borderline Level Deletion

Sheila J.M. O’Connor, PhD, Kathryn R Turner, MSc, Bradley Dickinson, MSc, Sharon L Barrans, PhD, Roger G Owen, Andrew Jack, PhD, MB, Peter Hillmen, MBChB, PhD
Journal: Blood
Blood (2008) 112 (11): 4178.
https://doi.org/10.1182/blood.V112.11.4178.4178
Published: 2008
Journal Articles

Abortive Plasma Cell Differentiation with Loss of Mature B-Cell Phenotype in a Subset of Patients with De Novo Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma: Relevance of cMYC Rearrangements.

Matthew J. Cullen, MSc, Sharon L. Barrans, PhD, Stephen J. Richards, PhD, Andy C. Rawstron, PhD, Sheila J.M. O’Connor, PhD, Reuben M. Tooze, PhD, Roger G. Owen, MD, Andrew Jack, MD
Journal: Blood
Blood (2006) 108 (11): 4643.
https://doi.org/10.1182/blood.V108.11.4643.4643
Published: 2006
Journal Articles

Tropical Splenic Lymphoma: Splenic Marginal Zone Lymphoma or Distinct Entity?.

Elizabeth A. Stephens, MBBS, Imelda Bates, MD, George Bedu-Addo, Ivy Ekem, Yvonne Dei, Ohene K. Opare-Sem, Sheila J.M. O’Connor, PhD, Paul A.S. Evans, PhD, Rebecca A. Rollett, BSc, Roger G. Owen, MD
Journal: Blood
Blood (2006) 108 (11): 4654.
https://doi.org/10.1182/blood.V108.11.4654.4654
Published: 2006
Journal Articles

Rearrangements of MALT1, IgH, FOXP1 , BCL3 and PAX5 Are Rare Events in Extranodal Marginal Zone Lymphoma in the UK.

Sharon L. Barrans, PhD, Kathryn Turner, MSc, Sheila J.M. O’Connor, PhD, Andrew S. Jack, MD, Roger G. Owen, MD
Journal: Blood
Blood (2006) 108 (11): 4639.
https://doi.org/10.1182/blood.V108.11.4639.4639
Published: 2006
Journal Articles

Disease Progression in Monoclonal B-Cell Lymphocytosis Is Independent of VH Mutation Status.

Fiona L. Bennett, BSc, James A.L. Fenton, DPhil, Sheila J.M. O’Connor, PhD, Peter Hillmen, MD, PhD, Andy C. Rawstron, PhD
Journal: Blood
Blood (2006) 108 (11): 29.
https://doi.org/10.1182/blood.V108.11.29.29
Published: 2006
Journal Articles

Increased Expression of CD200 Antigen, a Potential Immunotherapeutic Target, Is Consistently Found in CLL Cells Irrespective of Biological Features.

Fiona L. Bennett, BSc, Andy C. Rawstron, PhD, Sheila J.M. O’Connor, PhD, Paul A.S. Evans, PhD, Peter Hillmen, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 2815.
https://doi.org/10.1182/blood.V108.11.2815.2815
Published: 2006
Journal Articles

Cyclooxygenase-2 (COX-2) in Multiple Myeloma: Prognostic Marker or Therapeutic Target?.

Roger G. Owen, MD, Im Fan, MSc, Sheila J.M. O’Connor, Phd, Faith E. Davies, MD, Rebecca A. Rollett, BSc, J. Anthony Child, MD, Andy C. Rawstron, Phd
Journal: Blood
Blood (2006) 108 (11): 5051.
https://doi.org/10.1182/blood.V108.11.5051.5051
Published: 2006
Journal Articles

A Highly Effective Model of Risk Assessment in Diffuse Large B Cell Lymphoma (DLBCL) Using Classification and Regression Tree (CART) Analysis.

Sharon L. Barrans, PhD, Alex Smith, PhD, Sheila J.M. O’Connor, PhD, Kathryn Turner, MSC, Russell Patmore, MD, Roger G. Owen, MD, Eve Roman, PhD, Andrew Jack, MD
Journal: Blood
Blood (2005) 106 (11): 1918.
https://doi.org/10.1182/blood.V106.11.1918.1918
Published: 2005